Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries
1 other identifier
interventional
132
1 country
1
Brief Summary
The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after surgery. Participants will under combined cataract surgery and goniotomy. They will have post-operative follow up visits at 1 day, 1 week, 1 month, 3 months, and 6 month
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
February 18, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
Study Completion
Last participant's last visit for all outcomes
March 1, 2028
June 11, 2026
June 1, 2026
1.7 years
January 15, 2026
June 9, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Intraocular pressure
Eye pressure as measured by Goldmann applanation tonometry in mmHg
up to 6 months
Medications
number of medications to control intraocular pressure
up to 6 months
Visual Acuity
Measure of visual at each visit on Snellen acuity chart
up to 6 months
Study Arms (3)
SION
ACTIVE COMPARATORGoniotomy performed with SION
BANG
ACTIVE COMPARATORGoniotomy performed with bent needle
Tanito
ACTIVE COMPARATORGoniotomy performed with Tanito hook
Interventions
Goniotomy opens the trabecular meshwork to lower intraocular pressure.
Eligibility Criteria
You may qualify if:
- Diagnosed with primary or secondary open-angle glaucoma (e.g., POAG, pigmentary, pseudoexfoliative)
- Scheduled for phacoemulsification with planned goniotomy
- Able to provide informed consent
You may not qualify if:
- Angle-closure glaucoma
- Prior glaucoma surgery in the study eye
- Planned stand-alone goniotomy
- Inability to comply with follow-up schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Henry Ford Health
Detroit, Michigan, 48202, United States
Related Publications (5)
Rahul Hariharan Jayaram, Akash Maheshwari, Soshian Sarrafpour, Ji Liu, Christopher Teng; Trends for Glaucoma Surgeries in the United States from 2011 and 2021 - A National Study. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4641.
BACKGROUNDAktas Z, Dorairaj S, Sayed M, Sheybani A, Ucgul AY, Wagner I, Khodeiry M. Ab Interno Goniotomy/Goniectomy Techniques. Turk J Ophthalmol. 2025 Jun 25;55(3):159-170. doi: 10.4274/tjo.galenos.2025.29345. Epub 2025 May 29.
PMID: 40439165BACKGROUNDChihara E, Chihara T. Mid-Term Surgical Outcomes of T-Hook, 360 degrees Suture Trabeculotomy, Kahook Dual Blade, and Tanito Microhook Procedures: A Comparative Study. J Clin Med. 2025 Jun 29;14(13):4610. doi: 10.3390/jcm14134610.
PMID: 40648984BACKGROUNDShute T, Green W, Liu J, Sheybani A. An Alternate Technique for Goniotomy: Description of Procedure and Preliminary Results. J Ophthalmic Vis Res. 2022 Apr 29;17(2):170-175. doi: 10.18502/jovr.v17i2.10787. eCollection 2022 Apr-Jun.
PMID: 35765640BACKGROUNDBukke AN, Midha N, Mahalingam K, Beri N, Angmo D, Sharma N, Pandey S, Dada T. Outcomes of bent ab interno needle goniectomy with phacoemulsification in moderate to severe primary open angle glaucoma. Indian J Ophthalmol. 2024 Sep 1;72(9):1280-1284. doi: 10.4103/IJO.IJO_1072_24. Epub 2024 Jul 11.
PMID: 38990629BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David A Crandall, MD
Henry Ford Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 15, 2026
First Posted
February 18, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
June 11, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
There will be a publication based on the results of the study. We will not be sharing individual participant data outside of our institution and all collected data will be kept on a secured drive within the Henry Ford Health System.